Print
Anthem Blue Cross, California’s biggest for-profit health insurance company, has been on the hot seat lately. Its plan to raise premiums for individuals by as much as 39 percent landed the CEO of its parent company, Wellpoint, in front of a Congressional committee and reignighted efforts in Washington to pass healthcare reform legislation. Now the advocacy group ConsumerWatchdog has filed a class-action lawsuit against Anthem over the rate increases saying they violate California law. We spoke to Jerry Flanagan, healthcare policy director for ConsumerWatchdog, about his group’s lawsuit, what Anthem’s actions mean for reform, and why the proposed healthcare legislation wouldn’t have prevented Anthem from instituting the rate increases in the first place.
HEALTHCARE REFORM
Consumer Group Sues Over Health Insurance Increases
Podcast: March 8, 2010[Please login to post comments]
- Archimedes Does Some Math
Biopharma’s funding round is the largest private European financing in 15 years. Read More - A Humble Start for Anthera
Anthera Pharmaceuticals IPO gets done, but at just more than half of its $70 million target. Read More - Astellas Turns Up the Heat
Suitor sues OSI, adding pressure to its hostile bid. Read More - Keeping a Beat
Coffee associated with reduced risk of hospitalization for heart rhythm disturbances. Read More - Can’t Read You
Parkinson's disease makes it harder to figure out how other people feel. Deep brain stimulation seems to make it worse. Read More - Merck KgaA Outbids Thermo
German pharmaceutical and chemical giant snaps up Millipore for $7.2 billion in a bid to diversify its revenue stream. Read More - Surprise and Disappointment for Medivation and Pfizer over Alzheimer’s Drug Failure
The weekly round-up of failed trials, missed targets and other business mishaps. Read More - The World’s Tropical Zone – Rich Beauty, Rare Opportunity
Growth in wealth and population in the tropics is driving demand for solutions that are economical, environmentally sustainable and directly improve health and living conditions. Read More - March Roars in for Life Sciences
Something for everyone—a big acquisition, an attempt at a hostile takeover, and an anemic IPO. Read More - A Battle Brews for Control of Genzyme
Podcast: March 1, 2010 Read More
.gif)
.gif)
.gif)
- For Many House Democrats, Cost Is the Concern
The New York Times - End-of-Life Warning at $618,616 Makes Me Wonder Was It Worth It
Bloomberg - Obama’s Health-Care Path May Face ‘War’ in Congress
Bloomberg - In Final Push, Obama Urges ‘Up-or-Down’ Vote on Health
The New York Times - Consumer group sues California health insurer
Reuters - Industry crackdown on salt could save U.S. billions
Reuters - Democrats to Press Health Bill With Simple Majority
The New York Times - Obama to Highlight Cost in New Health Bill Push
The New York Times - What do we need health insurers for anyway?
The Los Angeles Times - Obama Tells McCain ‘Election’s Over’ at Health Summit
Bloomberg